Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis-Reference-Cited by-同舟云学术

Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis

Published:2020 Issue:38 Volume:44 Page:16626-16637
ISSN:1144-0546
Container-title:New Journal of Chemistry
language:en
Short-container-title:New J. Chem.

Author:

Peerzada Mudasir Nabi¹²³⁴⁵,Khan Parvez⁶³⁴⁵,Khan Nashrah Sharif⁶³⁴⁵⁷,Gaur Aysha¹²³⁴⁵,Avecilla Fernando⁸⁹¹⁰¹¹¹²,Hassan Md. Imtaiyaz⁶³⁴⁵^ORCID,Azam Amir¹²³⁴⁵^ORCID

Affiliation:

1. Medicinal Chemistry Research Laboratory

2. Department of Chemistry

3. Jamia Millia Islamia

4. New Delhi-110025

5. India

6. Centre for Interdisciplinary Research in Basic Sciences

7. Department of Biotechnology

8. Grupo Xenomar

9. Centro de Investigacións Científicas Avanzadas (CICA)

10. Departamento de Química

11. Facultade de Ciencias

12. Universidade da Coruña

Abstract

Interaction of compound32with various active site residues of MARK4.

Funder

Council of Scientific and Industrial Research

Science and Engineering Research Board

Indian Council of Medical Research

Department of Biotechnology, Ministry of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

Materials Chemistry,General Chemistry,Catalysis

Link

http://pubs.rsc.org/en/content/articlepdf/2020/NJ/D0NJ03474F

Reference56 articles.

1. An overview of the KIN1/PAR-1/MARK kinase family

2. MARK, a Novel Family of Protein Kinases That Phosphorylate Microtubule-Associated Proteins and Trigger Microtubule Disruption

3. The tau of MARK: a polarized view of the cytoskeleton

4. MARKK, a Ste20-like kinase, activates the polarity-inducing kinase MARK/PAR-1

5. Microtubule Affinity-Regulating Kinase 4: Structure, Function, and Regulation

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets;Pharmacology & Therapeutics;2024-02

2. Design, synthesis, molecular docking and anti-proliferative activity of novel phenothiazine containing imidazo[1,2-a]pyridine derivatives against MARK4 protein;RSC Medicinal Chemistry;2024

3. Naturbasierte bioinformatische Ansätze in der Arzneimittelforschung gegen vielversprechende molekulare Ziele – Carbonanhydrasen und Serin/Threonin-Kinasen zur Krebsbehandlung;Von der Natur inspirierte intelligente Datenverarbeitungstechniken in der Bioinformatik;2024

4. Privileged Scaffolds in Drug Discovery against Human Epidermal Growth Factor Receptor 2 for Cancer Treatment;Current Pharmaceutical Design;2023-12

5. Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases;Journal of Cellular Biochemistry;2023-09